Product NewsEndometrial Cancer Mutations Are Detectable In Uterine Lavage Fluid Before A Cancer Is Diagnosed
Industry NewsKey Advancement in Cancer Sequencing: Development of Next-Generation Sequencing for Somatic Mutation Detection
Industry NewsSwift Biosciences and TATAA Biocenter Announce Strategic Partnership to Distribute NGS Products in Europe
Industry NewsSilicon Biosystems Menarini, Swift Biosciences Announce Collaboration and CoMarketing Partnership to Unlock Genomic Information from FFPE Samples
Industry NewsSophia Genetics Partners with Swift Biosciences to Offer Combined Solution for Molecular Diagnostics in Europe
Product NewsSwift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
Industry NewsSwift Presents Solutions for Improving Whole Genome Sequencing on Illumina® Platforms at ASHG
Product NewsFluxion Biosciences and Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow for Somatic Mutation Detection from Liquid Biopsy Samples
Product NewsSwift Biosciences Launches Accel-NGS™ 2S DNA Library Kit – Dramatically Reduces Sample Requirements for NGS Sample Prep
Product NewsNew Accel-NGS™ PCR-free DNA Library Kit for Illumina Next Generation Sequencing Systems from Swift Biosciences, Inc.
Product NewsSwift Biosciences Announce Early Access Program for Illumina Next Generation Sequencing Systems
Product NewsSwift Biosciences Announce New Line of myT® Primer Reagents for Detection of Cancer Mutations
Industry NewsSwift Biosciences myT Primer Technology for the Detection of Somatic Mutations in Human Cancer
